Optigenex Inc. Announces Supply And License Agreement With Suracell Inc. To Utilize The AC-11(R) Trademark And Technology For Oral Supplements In The United States, Canada And South Korea
Wed Oct 21, 2009 9:01am EDT
Optigenex Inc. Announces Supply And License Agreement With Suracell Inc. To
Utilize The AC-11(R) Trademark And Technology For Oral Supplements In The
United States, Canada And South Korea
Company plans to market dietary supplements under the brand name Suracell
with AC-11(R) (Financial terms were not disclosed).
NEW YORK, Oct. 21 /PRNewswire-FirstCall/ - Optigenex Inc. (Pinksheets: OPGX)
announced today the signing of a Supply and Trademark License Agreement with
Suracell Inc. to provide its patented ingredient AC-11(R) for use in a focused
nutritional and age management dietary supplement program. The agreement
coupled with Suracell's marketing plans will provide another platform to
introduce Optigenex's technology under the registered trademark AC-11(R) to
health conscious consumers in the United States, Canada and South Korea.
Beginning in January 2010, Suracell will be marketing a specific dietary
supplement regimen. Participants will complete lifestyle questionnaires and
will be asked to provide specimens for testing of key bio markers that will
form the basis for a focused nutritional supplement program utilizing the
diverse line of Suracell formulated products with AC-11(R).
All-natural, herbal-extracted and patented AC-11(R) is marketed by over 100
manufacturers and marketing companies in Japan, Europe, the Middle East, the
United States and Canada in a variety of anti-aging cosmetic, dietary
supplement and advanced DNA care products.
Daniel Zwiren, president and CEO of Optigenex Inc. said, "We are excited to
add Suracell to our family of customers. We believe Suracell's scientifically
validated formulas are an ideal fit for the unique properties of AC-11(R),
including natural DNA repair, immune enhancement and inhibition of
pro-inflammatory agents. The licensing relationship we are entering into today
will allow both companies to expand significantly their respective businesses
and market penetration.
A Suracell spokesperson added, "The addition of AC -11(R) to the proprietary
customized Suracell formulations gives us a product line unparalleled in its
potential benefits to its customers. The evolving science surrounding AC 11(R)
promises a very exciting future for our product offerings.
About Suracell Inc.:
Suracell Inc. provides personal genetic health programs formulated to measure,
assess treat and monitor the body's individual genetic needs. The testing and
analysis programs are designed to pinpoint deficiencies and damage in an
individual's DNA and provide personalized recommended protocols consisting of
specially formulated nutraceuticals and positive lifestyle choices.
About Optigenex Inc.:
Optigenex Inc. (www.optigenex.com) is a formulator, distributor and provider
of proprietary next generation skin care, supplements and bulk ingredient
featuring AC-11(R) (formerly known as C-MED-100(R)), a patented compound, as
its core technology. AC- 11(R) is the bioactive, water-soluble form of the
medicinal herb Uncaria tomentosa. For more information about Optigenex please
email the company at: dzwiren@optigenex.com.
News 
Market Data 
Discover 
